4.3 Article

DNA polymerase θ (POLQ): A druggable DNA polymerase for homologous recombination-deficient cancer cells

期刊

BIOCELL
卷 47, 期 3, 页码 441-444

出版社

TECH SCIENCE PRESS
DOI: 10.32604/biocell.2023.025747

关键词

POLQ; Cancer; MMEJ; Targeted therapies

类别

向作者/读者索取更多资源

Irregularities in DNA repair pathways are common in cancer, with POLQ being an overexpressed DNA polymerase in tumor cells. In HR-deficient cells, POLQ-mediated microhomology-mediated end joining (MMEJ) is an important backup repair pathway.
Irregularities in the DNA repair pathways are frequently observed in cancer. Dysregulated DNA repair pathways support growth advantages to tumor cells. DNA polymerase-theta (POLQ) is an error-prone DNA polymerase involved in double-strand break repair through microhomology-mediated end joining (MMEJ). POLQ also mediates translesion DNA synthesis and it is largely not expressed in normal cells. POLQ is overexpressed in a range of cancer cells, including homologous recombination (HR) deficient cancer cells. In HR deficient cells, MMEJ is crucial as a backup DNA repair pathway, indicating the indispensable role of POLQ-mediated MMEJ in HR deficient cancer cells. In addition, POLQ is synthetic lethal with a number of oncogenes. This viewpoint highlights the potential role of POLQ as a new target in the treatment of HR-deficient tumors and aims to develop enthusiasm to introduce fundamental aspects of Molecular Biology and Biochemistry to basic research related to Molecular Life Sciences, Cell Biology and Genetics in Sri Lanka as Molecular Biology and Biochemistry fundamentals can still do wonders in modern research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据